MCC
CDTX

Money Concepts Capital’s Cidara Therapeutics CDTX Stock Holding History

Money Concepts Capital’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,750
Closed -$41.6K – 853
2022
Q4 		$41.6K Buy
+2,750
New +$32.8K ﹤0.01% 1320

Other funds holding CDTX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Money Concepts Capital's CDTX Position: Q1 2023 in Review

Money Concepts Capital sold out of Cidara Therapeutics (CDTX) in Q1 2023, closing a stake of 2,750 shares — an estimated $41.6K sold.

Money Concepts Capital first reported a position in CDTX in Q4 2022 and held it in 1 quarter. The position peaked at $41.6K in Q4 2022. 54 funds tracked by Wall St. Rank hold CDTX as of Q1 2023.

  • Money Concepts Capital reported no remaining Cidara Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 2,750 Cidara Therapeutics shares in Q1 2023, an estimated $41.6K.
  • Money Concepts Capital first reported a position in Cidara Therapeutics in Q4 2022 and held it in 1 quarter.
  • Money Concepts Capital's Cidara Therapeutics position peaked at $41.6K in Q4 2022.
  • 54 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.